Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2019-12-24 (6 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ALBERTVILLE (73200), Savoie
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE CROIX DE L'ORME : revenue, balance sheet and financial ratios
PHARMACIE CROIX DE L'ORME is a French company
founded 6 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ALBERTVILLE (73200),
this company of category PME
shows in 2025 a net income positive of 103 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE CROIX DE L'ORME (SIREN 880085204)
Indicator
2025
2024
2023
2022
2021
Revenue
N/C
N/C
N/C
N/C
N/C
Net income
103 347 €
104 024 €
84 415 €
63 834 €
55 718 €
EBITDA
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
En 2025, PHARMACIE CROIX DE L'ORME genera un resultado neto positivo de 103 k€. Evolución 2021-2025: 56 k€ -> 103 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
103 347 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
El ratio de endeudamiento (= Deuda financiera / Fondos propios x 100) se sitúa en 89%. El nivel de deuda es alto: el margen de negociación con los bancos se reduce. La autonomía financiera (= Fondos propios / Total activo x 100) alcanza el 42%. Esta alta autonomía significa que la empresa financia la mayoría de sus activos con fondos propios.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
89.047%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
41.67%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE CROIX DE L'ORME
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
2022
2023
2024
2025
Debt ratio
405.056
277.052
187.344
126.807
89.047
Financial autonomy
16.871
21.875
28.558
35.94
41.67
Repayment capacity
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
Sector positioning
Ratio de endeudamiento
89.052025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Average-12 pts over 3 years
En 2025, el ratio de endeudamiento de PHARMACIE CROIX DE L'ORME (89.05) se sitúa por encima de la mediana del sector. Este ratio mide el peso de la deuda en relación con el patrimonio. Un esfuerzo de reducción podría mejorar la solidez financiera.
Autonomía financiera
41.67%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Average+10 pts over 3 years
En 2025, el autonomía financiera de PHARMACIE CROIX DE L'ORME (41.7%) se sitúa por debajo de la mediana del sector. Este ratio representa la parte del patrimonio en la financiación total. Una mejora fortalecería la posición competitiva.
Liquidity ratios
El ratio de liquidez se sitúa en 139.04. La empresa tiene 2€ de activos líquidos por cada 1€ de deuda a corto plazo.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
139.044
Liquidity indicators evolution PHARMACIE CROIX DE L'ORME
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2021
2022
2023
2024
2025
Liquidity ratio
0.0
0.0
0.0
0.0
139.044
Interest coverage
None
None
None
None
None
Sector positioning
Ratio de liquidez
139.042025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Average+27 pts over 3 years
En 2025, el ratio de liquidez de PHARMACIE CROIX DE L'ORME (139.04) se sitúa por debajo de la mediana del sector. Este ratio mide la capacidad de cubrir deuda a corto plazo con activos corrientes. Una mejora fortalecería la posición competitiva.
Positioning of PHARMACIE CROIX DE L'ORME in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE CROIX DE L'ORME is estimated at
1 641 679 €
(range 1 114 051€ - 2 576 021€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1114k€1641k€2576k€
1 641 679 €Range: 1 114 051€ - 2 576 021€
NAF 5 année 2025
Valuation method used
Net Income Multiple
103 347 €
×
15.9x
=1 641 679 €
Range: 1 114 051€ - 2 576 021€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE CROIX DE L'ORME with other companies in the same sector:
Frequently asked questions about PHARMACIE CROIX DE L'ORME
What is the revenue of PHARMACIE CROIX DE L'ORME ?
The revenue of PHARMACIE CROIX DE L'ORME is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE CROIX DE L'ORME profitable?
Yes, PHARMACIE CROIX DE L'ORME generated a net profit of 103 k€ in 2025.
Where is the headquarters of PHARMACIE CROIX DE L'ORME ?
The headquarters of PHARMACIE CROIX DE L'ORME is located in ALBERTVILLE (73200), in the department Savoie.
Where to find the tax return of PHARMACIE CROIX DE L'ORME ?
The tax return of PHARMACIE CROIX DE L'ORME is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE CROIX DE L'ORME operate?
PHARMACIE CROIX DE L'ORME operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart